NextCure

July 14, 2020

Nextcure’s flash in the pan fizzles out

November 11, 2019

SITC – the morning after the night before

Nextcure’s Society for Immunotherapy of Cancer presentation gave investors little reason for cheer, but there's better news for Pieris, Celyad and Nektar.

November 06, 2019

SITC – Nextcure investors value a cancer remission

October 09, 2019

SITC 2019 preview – Nextcure’s time to shine

The biotech calendar’s next key conference gets under way in a month, and a presentation by Nextcure will be a focus for some investors.

July 14, 2016

Biotech venture funding falls from 2015 peak

April 13, 2016

First-quarter venture financing: the retrenchment begins

March 14, 2016

NextCure

Nextcure’s flash in the pan fizzles out

SITC – the morning after the night before

SITC – Nextcure investors value a cancer remission

SITC 2019 preview – Nextcure’s time to shine

Biotech venture funding falls from 2015 peak

First-quarter venture financing: the retrenchment begins

VC funding – Europe keeps up the pace while US slows

Latest Reports

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2020

Evaluate Vantage COVID-19 Report

Editor's Picks

Esmo 2020 preview – late-breaking immunotherapy

Esmo 2020 preview – a kidney cancer showdown gets star billing

More biotechs test the third way to market

Abbott rides to the rescue with $5 Covid-19 test

Are the stars waning for Pfizer’s haemophilia A gene therapy?